|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 64.70 USD | +4.81% |
|
-3.52% | +14.21% |
| 11-10 | Lattice Semiconductor Insider Bought Shares Worth $1,892,115, According to a Recent SEC Filing | MT |
| 11-04 | The Bull Market Meets Its Therapist |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 5.45 | 9.15 | 15.61 | 16.33 | 4.5 | |||||
Return on Total Capital | 6.53 | 10.97 | 19.34 | 19.92 | 5.28 | |||||
Return On Equity % | 13.31 | 24.1 | 39.8 | 43.94 | 8.71 | |||||
Return on Common Equity | 13.31 | 24.1 | 39.8 | 43.94 | 8.71 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 60.11 | 62.42 | 68.46 | 69.82 | 66.82 | |||||
SG&A Margin | 23.36 | 20.5 | 18.49 | 18.62 | 24.63 | |||||
EBITDA Margin % | 19.96 | 24.71 | 33.28 | 33.73 | 19.52 | |||||
EBITA Margin % | 14.92 | 20.48 | 29.41 | 29.53 | 12.83 | |||||
EBIT Margin % | 13.8 | 19.97 | 28.84 | 29.05 | 11.91 | |||||
Income From Continuing Operations Margin % | 11.61 | 18.61 | 27.09 | 35.14 | 12 | |||||
Net Income Margin % | 11.61 | 18.61 | 27.09 | 35.14 | 12 | |||||
Net Avail. For Common Margin % | 11.61 | 18.61 | 27.09 | 35.14 | 12 | |||||
Normalized Net Income Margin | 8.02 | 12.1 | 17.53 | 18.38 | 7.66 | |||||
Levered Free Cash Flow Margin | 16.14 | 23.48 | 22.23 | 23.72 | 22.06 | |||||
Unlevered Free Cash Flow Margin | 16.61 | 23.74 | 22.62 | 23.97 | 22.09 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.63 | 0.73 | 0.87 | 0.9 | 0.6 | |||||
Fixed Assets Turnover | 6.55 | 8.33 | 10.39 | 11.41 | 7.78 | |||||
Receivables Turnover (Average Receivables) | 5.8 | 6.62 | 7.07 | 6.8 | 4.75 | |||||
Inventory Turnover (Average Inventory) | 2.72 | 2.93 | 2.34 | 2.13 | 1.67 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 4.19 | 2.84 | 2.98 | 3.78 | 3.66 | |||||
Quick Ratio | 3.17 | 2.04 | 1.94 | 2.5 | 2.36 | |||||
Operating Cash Flow to Current Liabilities | 1.15 | 1.58 | 1.87 | 2.77 | 1.41 | |||||
Days Sales Outstanding (Average Receivables) | 63.94 | 55 | 51.51 | 53.56 | 76.64 | |||||
Days Outstanding Inventory (Average Inventory) | 136.24 | 124.24 | 155.49 | 171.13 | 217.79 | |||||
Average Days Payable Outstanding | 77.33 | 57.5 | 55.55 | 66.03 | 74.77 | |||||
Cash Conversion Cycle (Average Days) | 122.85 | 121.74 | 151.46 | 158.67 | 219.66 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 50.4 | 44.43 | 30.55 | 2.36 | 2.57 | |||||
Total Debt / Total Capital | 33.51 | 30.76 | 23.4 | 2.3 | 2.5 | |||||
LT Debt/Equity | 46 | 38.87 | 29.22 | 1.55 | 1.75 | |||||
Long-Term Debt / Total Capital | 30.59 | 26.91 | 22.39 | 1.52 | 1.7 | |||||
Total Liabilities / Total Assets | 43.47 | 43.34 | 39.01 | 17.7 | 15.76 | |||||
EBIT / Interest Expense | 15.21 | 37.59 | 45.93 | 72.19 | 228.11 | |||||
EBITDA / Interest Expense | 24.05 | 49.4 | 54.84 | 86.42 | 405.69 | |||||
(EBITDA - Capex) / Interest Expense | 20.78 | 45.81 | 49.21 | 79.65 | 326.8 | |||||
Total Debt / EBITDA | 2.18 | 1.35 | 0.65 | 0.06 | 0.17 | |||||
Net Debt / EBITDA | 0.13 | 0.38 | 0.01 | -0.44 | -1.09 | |||||
Total Debt / (EBITDA - Capex) | 2.52 | 1.46 | 0.73 | 0.07 | 0.21 | |||||
Net Debt / (EBITDA - Capex) | 0.15 | 0.41 | 0.02 | -0.47 | -1.36 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 1 | 26.27 | 28.14 | 11.63 | -30.9 | |||||
Gross Profit, 1 Yr. Growth % | 2.89 | 31.13 | 40.53 | 13.85 | -33.86 | |||||
EBITDA, 1 Yr. Growth % | -15.48 | 56.37 | 72.55 | 13.13 | -60.01 | |||||
EBITA, 1 Yr. Growth % | -21.27 | 73.72 | 84.01 | 12.07 | -70.11 | |||||
EBIT, 1 Yr. Growth % | -11.62 | 82.81 | 85.01 | 12.47 | -71.67 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 8.96 | 102.4 | 86.49 | 44.82 | -76.4 | |||||
Net Income, 1 Yr. Growth % | 8.96 | 102.4 | 86.49 | 44.82 | -76.4 | |||||
Normalized Net Income, 1 Yr. Growth % | 0.93 | 90.36 | 85.66 | 16.62 | -71.19 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 6.25 | 97.06 | 89.55 | 45.67 | -76.22 | |||||
Accounts Receivable, 1 Yr. Growth % | -0.42 | 21.85 | 18.51 | 14.01 | -14.39 | |||||
Inventory, 1 Yr. Growth % | 17.5 | 4.64 | 63.29 | -10.46 | 4.64 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -1.56 | 0.11 | 5.32 | -1.8 | 4.41 | |||||
Total Assets, 1 Yr. Growth % | 11.12 | 6.83 | 9.94 | 5.28 | 0.36 | |||||
Tangible Book Value, 1 Yr. Growth % | 108 | -39.88 | 120.68 | 142.4 | 9.92 | |||||
Common Equity, 1 Yr. Growth % | 17.33 | 7.08 | 18.35 | 42.05 | 2.73 | |||||
Cash From Operations, 1 Yr. Growth % | -26.14 | 82.93 | 42.38 | 12.89 | -47.74 | |||||
Capital Expenditures, 1 Yr. Growth % | -22.25 | -18.86 | 137.3 | -13.88 | 4.41 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -26.99 | 83.67 | 21.69 | 19.46 | -35.74 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -29.31 | 80.47 | 22.11 | 18.3 | -36.32 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 1.16 | 12.93 | 27.2 | 19.6 | -12.17 | |||||
Gross Profit, 2 Yr. CAGR % | 5.73 | 16.15 | 35.75 | 26.49 | -13.22 | |||||
EBITDA, 2 Yr. CAGR % | 9.19 | 14.96 | 64.26 | 39.72 | -32.74 | |||||
EBITA, 2 Yr. CAGR % | 13.07 | 16.88 | 78.79 | 43.61 | -42.14 | |||||
EBIT, 2 Yr. CAGR % | 37.81 | 27.11 | 83.91 | 44.25 | -43.55 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 34.18 | 48.51 | 94.28 | 64.34 | -41.54 | |||||
Net Income, 2 Yr. CAGR % | 34.18 | 48.51 | 94.28 | 64.34 | -41.54 | |||||
Normalized Net Income, 2 Yr. CAGR % | 144.29 | 38.61 | 88 | 47.42 | -41.93 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 27.24 | 44.7 | 93.27 | 66.17 | -41.14 | |||||
Accounts Receivable, 2 Yr. CAGR % | 0.11 | 10.16 | 20.17 | 16.24 | -1.2 | |||||
Inventory, 2 Yr. CAGR % | -1.88 | 10.88 | 30.71 | 20.92 | -3.21 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 33.15 | -0.73 | 2.68 | 1.7 | 1.26 | |||||
Total Assets, 2 Yr. CAGR % | 4.42 | 8.95 | 8.37 | 7.59 | 2.79 | |||||
Tangible Book Value, 2 Yr. CAGR % | 90.79 | 11.83 | 15.19 | 131.28 | 63.24 | |||||
Common Equity, 2 Yr. CAGR % | 21.96 | 12.08 | 12.57 | 29.66 | 20.8 | |||||
Cash From Operations, 2 Yr. CAGR % | 33.48 | 16.24 | 61.39 | 26.78 | -23.19 | |||||
Capital Expenditures, 2 Yr. CAGR % | 20.24 | -20.57 | 38.76 | 42.95 | -5.18 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 88.71 | 15.8 | 49.73 | 20.4 | -12.38 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 52.52 | 12.95 | 48.45 | 20.19 | -13.21 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 1.88 | 8.92 | 17.79 | 21.78 | -0.38 | |||||
Gross Profit, 3 Yr. CAGR % | 4.24 | 13.6 | 23.77 | 28.02 | 1.9 | |||||
EBITDA, 3 Yr. CAGR % | 18.43 | 23.08 | 31.63 | 45.06 | -7.92 | |||||
EBITA, 3 Yr. CAGR % | 38.18 | 30.39 | 35.97 | 53.02 | -14.76 | |||||
EBIT, 3 Yr. CAGR % | 85.39 | 51.42 | 44.05 | 56.1 | -16.15 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -12.43 | 53.89 | 60.22 | 76.16 | -13.94 | |||||
Net Income, 3 Yr. CAGR % | -12.43 | 53.89 | 60.22 | 76.16 | -13.94 | |||||
Normalized Net Income, 3 Yr. CAGR % | 19.53 | 124.8 | 52.79 | 60.54 | -14.45 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -16.31 | 47.21 | 58.33 | 75.89 | -13.08 | |||||
Accounts Receivable, 3 Yr. CAGR % | 8.4 | 6.89 | 12.87 | 18.08 | 4.97 | |||||
Inventory, 3 Yr. CAGR % | -6.84 | 0.25 | 26.15 | 15.23 | 15.23 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 15.23 | 21.07 | 1.25 | 1.17 | 2.6 | |||||
Total Assets, 3 Yr. CAGR % | 2.26 | 5.22 | 9.28 | 7.33 | 5.12 | |||||
Tangible Book Value, 3 Yr. CAGR % | 3.03 | 29.83 | 40.27 | 47.61 | 80.49 | |||||
Common Equity, 3 Yr. CAGR % | 20.87 | 16.78 | 14.13 | 21.65 | 19.98 | |||||
Cash From Operations, 3 Yr. CAGR % | 33.53 | 48.27 | 24.37 | 43.26 | -5.65 | |||||
Capital Expenditures, 3 Yr. CAGR % | -1.94 | 5.46 | 14.39 | 18.36 | 28.74 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 19.77 | 87.02 | 17.61 | 38.74 | -2.34 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 12.11 | 61.32 | 15.92 | 37.63 | -2.75 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 0.11 | 3.83 | 11.34 | 13.07 | 4.74 | |||||
Gross Profit, 5 Yr. CAGR % | 1.65 | 5.43 | 15.85 | 18.59 | 7.38 | |||||
EBITDA, 5 Yr. CAGR % | 30.52 | 16.61 | 34.99 | 29.48 | 0.63 | |||||
EBITA, 5 Yr. CAGR % | 52.02 | 27.29 | 53.12 | 35.52 | -3.29 | |||||
EBIT, 5 Yr. CAGR % | 8.29 | 106.55 | 84.8 | 48.51 | -0.97 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -21.52 | 12.14 | 20.45 | 57.99 | 7.05 | |||||
Net Income, 5 Yr. CAGR % | -21.52 | 12.14 | 20.45 | 57.99 | 7.05 | |||||
Normalized Net Income, 5 Yr. CAGR % | -1.48 | 36.14 | 43.27 | 89.89 | 3.77 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -24.21 | 8.25 | 16.97 | 54.52 | 6.58 | |||||
Accounts Receivable, 5 Yr. CAGR % | -4.52 | -3.01 | 12.96 | 10.54 | 7.02 | |||||
Inventory, 5 Yr. CAGR % | -3.17 | -3.11 | 6.67 | 8.05 | 13.47 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 3.59 | 4.58 | 10.03 | 12.92 | 1.25 | |||||
Total Assets, 5 Yr. CAGR % | -2.85 | -1.08 | 4.66 | 6.16 | 6.64 | |||||
Tangible Book Value, 5 Yr. CAGR % | -2.36 | -10.87 | 7.73 | 63.57 | 49.04 | |||||
Common Equity, 5 Yr. CAGR % | 4.7 | 8.77 | 17.48 | 21.77 | 16.76 | |||||
Cash From Operations, 5 Yr. CAGR % | 31.99 | 32.07 | 44.04 | 39.27 | 2.56 | |||||
Capital Expenditures, 5 Yr. CAGR % | -7.82 | -10.07 | 12.67 | 19.11 | 6.12 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 22.28 | 21.98 | 30.8 | 56.72 | 4.49 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 15.66 | 16.85 | 25.43 | 43.4 | 3.25 |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















